Cuban scientists advance in the development of a therapeutic vaccine against prostate cancer, which strikes mature men in the Caribbean causing more than 2,000 deaths per year in Cuba, said a researcher.
This project entered its third phase after passing the first two, in which encouraging results were recorded in stopping the progression of the disease and even recede it, said the scientist Roberto Basulto.
This vaccine is given in seven shots “and the body develops antibodies to the peptide,” Basulto, head of the research team, said.
Basulto and his colleagues at the Center for Genetic Engineering and Biotechnology in Camagüey, 530 km east of Havana, stressed that it is not a preventive vaccine but intended to “improve the quality of life” of patients.
Cuba Headlines, July 6, 2015